PATENTED INGREDIENT

Bonepep® Japanese Egg Yolk Peptide (Bone Health)

Bonepep® Japanese Egg Yolk Peptide (Bone Health) is a patented ingredient in the ACC Biotech catalogue, developed by Pharma Foods International Co., Ltd., with Japan listed as its origin. This page brings together the ingredient information currently available from ACC Biotech and the enquiry route.

INGREDIENT PROFILE

What this ingredient is documented for

Origin: Japan
Developer: Pharma Foods International Co., Ltd.

Egg yolk hydrolysate ("bone peptide", BP), developed by Pharma Foods (Japan) via enzymatic hydrolysis of the water-soluble fraction of defatted egg yolk
86.9% low-molecular-weight peptides (100–5,000 Da) and 82% protein for good bioavailability
Cell and animal studies show it promotes osteoblast activity and BMP-2 expression, raising the bone-formation marker BAP
Helps maintain bone density and slow the decline in bone formation in orchidectomized dogs and ovariectomized rats
Effective dose ~2 mg/kg (ED50 1.6 mg/kg); low fat and moisture, passes heavy-metal and microbial testing, 3-year shelf life

QUICK REFERENCE

Key ingredient facts

Origin: Japan
Developer: Pharma Foods International Co., Ltd.

About Bonepep® Japanese Egg Yolk Peptide (Bone Health)

Frequently asked questions

These answers summarize ACC Biotech's current catalogue information and enquiry process.

What information is available for Bonepep® Japanese Egg Yolk Peptide (Bone Health)?

This page summarizes the ingredient highlights, origin and developer information currently held in the ACC Biotech catalogue.

How can I request formulation, documentation or sourcing details?

Contact ACC Biotech with the intended dosage form, market and document requirements so the team can follow up with the relevant information.

MORE INGREDIENTS

FORMULATION

Discuss this ingredient with ACC

Bring this ingredient into a formula, documentation and sourcing conversation with the ACC team.